COO · The Cooper Companies, Inc.
$61.21
-0.71% last session
End-of-day data · close of 2026-10-23
Market cap
$12B
Enterprise value
$14B
Trailing P/E
21.0
Forward P/E
13.0
Dividend yield
0.0%
Beta
0.82
Avg volume
3M
Employees
15K
Daily Change %
-0.71%
5 Days Change
6.40%
10 Days Change
12.93%
30 Days Change
9.95%
60 Days Change
-18.67%
Month to Day Change
7.39%
Year to Day Change
-24.78%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — COO
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-07
Latest call per bank · past 12 months
Barclays
Equal-Weight$60.00
-2.0% vs priceWells Fargo
Equal-Weight$61.00
-0.3% vs priceCitigroup
Neutral$60.00
-2.0% vs priceJP Morgan
Neutral$58.00
-5.2% vs priceUBS
Neutral$66.00
+7.8% vs priceBank of America
Neutral$65.00
+6.2% vs priceMorgan Stanley
Equal-Weight$83.00
+35.6% vs priceGoldman Sachs
Sell$71.00
+16.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-07 | Barclays | Initiates | Equal-Weight | $0.00 → $60.00 |
| 2026-09-15 | Needham | Reiterates | Buy | $73.00 |
| 2026-09-11 | Mizuho | Maintains | Outperform | $85.00 → $75.00 |
| 2026-09-10 | William Blair | Downgrade | Outperform → Market Perform | $0.00 |
| 2026-09-10 | Wells Fargo | Maintains | Equal-Weight | $66.00 → $61.00 |
| 2026-09-10 | Stifel | Maintains | Buy | $85.00 → $70.00 |
| 2026-09-10 | Citigroup | Maintains | Neutral | $80.00 → $60.00 |
| 2026-09-10 | Piper Sandler | Downgrade | Overweight → Neutral | $86.00 → $59.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 61 — neutral momentum, neither overbought nor oversold.
- bearish: Price vs 50-day MA: Trading 1.1% below the 50-day MA ($61.92).
- bearish: Price vs 200-day MA: Trading 11.9% below the 200-day MA ($69.46).
- bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- bullish: MACD (12,26,9): MACD histogram is positive (+1.08) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($53.27) and high ($84.32).
COO Price Chart
Loading chart for COO…
Fundamentals
About The Cooper Companies, Inc.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$160B -21.6% YTD
BDX
Becton, Dickinson and Company
$54B 33.9% YTD
MDLN
Medline Inc.
$46B -17.0% YTD
RMD
ResMed Inc.
$36B 5.9% YTD
ALC
Alcon Inc.
$34B -9.9% YTD
WST
West Pharmaceutical Services, I
$28B 43.5% YTD
SOLV
Solventum Corporation
$15B 10.4% YTD
BAX
Baxter International Inc.
$13B 34.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.